Glibenclamide is a second-generation sulfonylurea used to treat type 2 diabetes by stimulating the pancreas to release insulin, thereby improving glycemic control. To support the rigorous analysis of this… Read more































Glibenclamide is a second-generation sulfonylurea used to treat type 2 diabetes by stimulating the pancreas to release insulin, thereby improving glycemic control. To support the rigorous analysis of this medication, laboratories utilize a comprehensive range of reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and hydroxylated metabolites. These analytical tools are essential for impurity profiling, method validation, and ensuring the precision of quality control testing. Furthermore, the inclusion of stable isotope-labeled compounds allows for accurate quantification through mass spectrometry, serving as reliable internal standards during complex bioanalytical studies. Whether performing routine batch release or investigating potential degradation products, these materials provide the necessary support for maintaining compliance with regulatory standards for this widely prescribed antidiabetic agent.